Science Daily: Pharmacology News

MAY 31, 2024

Scientists have discovered a highly effective, nontoxic, and less expensive way to lure hungry termites to their doom.

330

330

Drugs.com

MAY 31, 2024

FRIDAY, May 31, 2024 -- Caffeine has been associated with a reduced risk of developing Parkinson’s disease, but a new study says a coffee jolt might not be good for people already diagnosed with the brain disorder. Consuming caffeine appears.

Disease 252

Disease 252

Science Daily: Pharmacology News

MAY 31, 2024

Mars has a distinct structure in its mantle and crust with discernible reservoirs, and this is known thanks to meteorites that scientists have analyzed. These results are important for understanding not only how Mars formed and evolved, but also for providing precise data that can inform recent NASA missions like Insight and Perseverance and the Mars Sample Return.

309

309

Drugs.com

MAY 31, 2024

FRIDAY, May 31, 2024 -- Ambulances meant for people having a mental health crisis could help folks get the care they need with less confrontation and friction, a new study says. People transported to the hospital by a “psychiatric.

Hospitals 246

Hospitals 246

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

BioPharma Drive: Drug Pricing

MAY 31, 2024

Ahead of an advisory panel meeting, agency staff identified several sticking points in the clinical results backing Lykos’ ecstasy-based treatment for PTSD.

Therapies 225

Therapies FDA Treatment 225

Covalent Modifiers

MAY 31, 2024

Gary Tin, Marko Cigler, Matthias Hinterndorfer, Kevin D. Dong, Hana Imrichova, Steven P. Gygi, Georg E. Winter, Bioorganic & Medicinal Chemistry Letters , 2024 [link] Targeted protein degradation is mediated by small molecules that induce or stabilize protein–protein interactions between targets and the ubiquitin–proteasome machinery. Currently, there remains a need to expand the repertoire of viable E3 ligases available for hijacking.

Targeted Protein Degradation 189

Targeted Protein Degradation Small Molecule 189

Drugs.com

MAY 31, 2024

FRIDAY, May 31, 2024 -- The wee hours of the morning could be the most dangerous for someone on the brink of suicide or homicide, a new study shows. There’s a five-fold greater risk for suicide and an eight-fold greater risk for homicide.

245

245

BioPharma Drive: Drug Pricing

MAY 31, 2024

Regeneron and Sanofi now expect an FDA verdict in September. Elsewhere, Summit claimed victory over Keytruda and Neurocrine’s longtime CEO revealed plans to step down.

FDA 176

FDA 176

Drugs.com

MAY 31, 2024

FRIDAY, May 31, 2024 -- While LGBTQ+ people have higher risk factors for cancer, they are apt to face discrimination when in need of high-quality medical care, a new report shows. In particular, LGBTQ+ people have to worry that a health care.

233

233

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Covalent Modifiers

MAY 31, 2024

Saidbakhrom Saidjalolov, Filipe Coelho, Vincent Mercier, Dimitri Moreau, and Stefan Matile ACS Central Science 2024 10 (5), 1033-1043 DOI: 10.1021/acscentsci.3c01601 Thiol-mediated uptake (TMU) is an intriguing enigma in current chemistry and biology. While the appearance of cell-penetrating activity upon attachment of cascade exchangers (CAXs) has been observed by many and is increasingly being used in practice, the molecular basis of TMU is essentially unknown.

Science 147

Science 147

Drugs.com

MAY 31, 2024

FRIDAY, May 31, 2024 -- About one in eight U.S. seniors will be treated for a traumatic brain injury, typically during a fall, a new study finds. Medicare data shows that about 13% of seniors suffered a severe concussion during an average follow-up.

224

224

BioPharma Drive: Drug Pricing

MAY 31, 2024

Results from a trial called ASC4FIRST show Scemblix outperformed Gleevec and other kinase inhibitors in treating newly diagnosed chronic myeloid leukemia.

Trials 141

Trials Drugs 141

Drugs.com

MAY 31, 2024

FRIDAY, May 31, 2024 -- People who regularly stay up until the wee hours of the morning could be harming their mental health, a new study finds. Regardless of whether people were morning larks or a night owls, they tended to have higher rates of.

161

161

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Drug Patent Watch

MAY 31, 2024

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five… Source

Drugs 80

Drugs Marketing 80

Agency IQ

MAY 31, 2024

BY RACHEL COE, MSC Months overdue, the FDA’s Platform Technologies Designation guidance document has just been published by the agency. AgencyIQ breaks down what the designation means for sponsors and its limits for product sponsors. As part of the 2023 Consolidated Appropriations Act (Section 2503), Congress directed FDA to establish a new “Platform Technologies Designation” program.

FDA 59

FDA Production 59

Drug Patent Watch

MAY 31, 2024

Brivaracetam is the generic ingredient in two branded drugs marketed by Ucb Inc, Aurobindo Pharma Ltd, Lupin Ltd, Sunshine, and Zydus Pharms and, and is included in seven NDAs.

Drugs 80

Drugs Marketing 80

Agency IQ

MAY 31, 2024

BY WALKER LIVINGSTON, ESQ In this returning feature, AgencyIQ looks at public data to determine what the EPA is planning to do in the month ahead, including deadlines, meetings, events, planned regulations, comment periods, and more. The EPA has delayed the release of several TSCA risk management rules for existing chemicals – these may be released in June.

Regulations 59

Regulations 59

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Drug Patent Watch

MAY 31, 2024

This chart shows the drugs with the most patents in Czech Republic.

Drugs 59

Drugs Pharmaceuticals 59

Agency IQ

MAY 31, 2024

BY LAURA DIANGELO, MPH In May 2024, the FDA’s Molecular and Clinical Genetics Device panel voted 7-2 in favor of the approval of a new blood-based screening test for colorectal cancer, which would be the first blood-based test of this type. Discussions at the panel meeting highlighted questions about the role of screening tests and their place in the clinical workflow, labeling for screening indications, and the challenges of studying “repeat” tests.

59

59

Drug Patent Watch

MAY 31, 2024

Annual Drug Patent Expirations for ANGIOMAX+RTU Angiomax Rtu is a drug marketed by Maia Pharms Inc and is included in one NDA. It is available from three suppliers.

Drugs 59

Drugs Marketing 59

Agency IQ

MAY 31, 2024

BY SEBASTIAN GODOY, MPH , KIRSTEN MESSMER, PHD, RAC , COREY JASEPH, MS, RAC , KARI OAKES , CHELSEY MCINTYRE, PHARMD In this recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods, and more.

Regulations 59

Regulations Science 59

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

Drug Patent Watch

MAY 31, 2024

Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA. It is available from one supplier.

Drugs 59

Drugs Marketing 59

Agency IQ

MAY 31, 2024

BY SCOTT STEPHENS, MPA Welcome to AgencyIQ’s monthly roundup of EU chemical sector activities. This recurring feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars, meetings, and more.

Regulations 59

Regulations 59

Perficient: Drug Development

MAY 31, 2024

In Salesforce, data storage and configuration management are crucial for maintaining robust and scalable applications. Two powerful tools that Salesforce developers and administrators frequently use to handle this are Custom Metadata Types and Custom Settings. While both serve unique purposes, they offer distinct benefits and come with their own best practices.

Packaging 59

Packaging Production 59

The ChEMBL-og

MAY 31, 2024

In 2024 we celebrate the 15th anniversary of the first public release of the ChEMBL database as well as the 10th anniversary of SureChEMBL. To recognise this important landmark we are organising a two-day symposium to celebrate the work achieved by ChEMBL and SureChEMBL, and look forward to its future. Save the date for the ChEMBL 15 Year Symposium October 1-2, 2024 Day one will consist of four workshops, a basic ChEMBL drug design workshop; an advanced ChEMBL workshop (EUbOPEN community worksho

Drugs 54

Drugs 54

Perficient: Drug Development

MAY 31, 2024

In today’s data-driven world, protecting sensitive information is more crucial than ever. Salesforce Field Encryption provides organizations with a powerful tool to ensure their most critical data remains secure, even in the face of potential security breaches. In this comprehensive guide, we’ll walk you through the fundamentals of Salesforce Field Encryption, offering insights into its functionalities and best practices for seamless implementation.

Compliance 59

Compliance Government 59

Fierce BioTech

MAY 31, 2024

GxP AI - How Quality Systems Can Responsibly Control AI to Enhance Productivity and Streamline Operations swheeler Fri, 05/31/2024 - 15:04 Wed, 07/10/2024 - 11:00 Resource Type Webinar Bryan Ennis Jamie Hijimans Michelle Vuolo Duration 60 minutes As AI capabilities push into GxP regulated business functions, how can Quality and IT teams partner to ensure they are properly controlled?

Production 52

Production Regulations Science 52

Drug Channels

MAY 31, 2024

Today’s guest post comes from Jan Nielsen, Patient Solutions Division President at AssistRx. Jan discusses the challenges facing life sciences organizations’ patient support program reverification processes. Jan then highlights how the right vendor can help overcome these challenges for both pharmacy and medical benefit products. She offers real-world examples how of AssistRx implements these solutions for clients.

Pharmacy 52

Pharmacy Science Therapies Production 52

Perficient: Drug Development

MAY 31, 2024

Do you e ver wish you had more time to focus on strategic thinking , to wrap your arms around a long-term vision, instead of spending your days drowning in admin istrative tasks ? D igging deep into your idea factory takes time and energy, and a never-ending cycle of burn reports, meetings, a nd timecard approvals can drain both – pushing innovation to the back burner.

52

52